Azafaros
Developer of therapeutic agents designed for the treatment of rare metabolic disorders through oral administration of aza-sugar compounds. The company develops drugs that address lysosomal storage dis...
Valuation
$0
Share Price
N/A
Total Raised
$184.6M
Last Round
N/A